Search Results 31-40 of 16278 for Chronic Lymphocytic Leukemia
Mayo Clinic doctors and researchers are studying the latest in diagnosis and treatment of acute lymphocytic leukemia. The Hematologic Malignancies Program ...
This study is designed to evaluate PFS endpoint for acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia. Participation eligibility.
... chronic lymphocytic leukemia (r/r CLL) and Small Lymphocytic Lymphoma (r/r SLL). Participation eligibility. Participant eligibility includes age, gender ...
Chronic lymphocytic leukemia · Hairy cell leukemia; Large granular lymphocyte disorders; Lymphocytosis; Natural killer cell leukemia; Prolymphocytic leukemia.
Diagnosis of B-cell CLL established according to International Workshop on Chronic Lymphocytic Leukemia (iwCLL) criteria and documented within medical records.
Mayo Clinic hematopathologists use the latest in laboratory testing to provide you with an accurate diagnosis. Specialized tests can analyze leukemia cells ...
This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come ...
... chronic lymphocytic leukemia (CLL) with 17p deletion. An increased rate of deaths and serious adverse events (SAEs) among participants with front-line CLL ...
... Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL). Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating ...
... chronic lymphocytic leukemia. Ibrutinib may stop the growth of cancer cells ... Giving ibrutinib and obinutuzumab with venetoclax may work better at treating ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Their crucial work saves lives every day. Let Mayo Clinic researchers know they’re appreciated with a quick message.